Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

26.91 +0.72 (+2.75%)
Streaming Delayed Price Updated: 1:13 PM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,758,420
Open 26.48
Bid (Size) 26.90 (100)
Ask (Size) 26.92 (500)
Prev. Close 26.19
Today's Range 25.96 - 27.33
52wk Range 13.74 - 70.43
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗
This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic? 
Via The Motley Fool
News headline image
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
From Hims & Hers
Via Business Wire

Performance

YTD
-19.5%
-19.5%
1 Month
-4.8%
-4.8%
3 Month
+21.4%
+21.4%
6 Month
-31.2%
-31.2%
1 Year
-52.7%
-52.7%

More News

Read More
News headline image
1 Growth Stock Set to Flourishand 2 We Ignore
Via StockStory
Topics Economy
News headline image
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
From Hims & Hers
Via Business Wire
News headline image
2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds
Via StockStory
News headline image
Is Hims & Hers Stock an Undervalued Stock to Buy? ↗
Via The Motley Fool
News headline image
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗
Via Benzinga
News headline image
The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗
Via MarketBeat
Topics Earnings
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
Via FinancialNewsMedia
Topics Government
News headline image
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
From Hims & Hers
Via Business Wire
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Hims & Hers Massive Stock Drop Explained ↗
Via The Motley Fool
News headline image
Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering ↗
Via Benzinga
News headline image
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
News headline image
5 Revealing Analyst Questions From Hims & Hers Health’s Q1 Earnings Call
Via StockStory
Topics Earnings Economy
News headline image
Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1
Via StockStory
News headline image
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is Hims and Hers Health Stock a Buy After Its Latest Dip? ↗
Via The Motley Fool
News headline image
1 Small-Cap Stock to Target This Week and 2 We Turn Down
Via StockStory
A Hot CPI, Chips in Retreat, and $100 Oil: Tuesday's Market in Four Acts ↗
Via Chartmill
News headline image
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery? ↗
Via MarketBeat
Topics Intellectual Property Lawsuit
News headline image
Why Hims & Hers Health Stock Just Crashed ↗
Via The Motley Fool
Topics Earnings Lawsuit

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 26.91
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 06/08/26 01:13 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 5.16B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.